1. Home
  2. XPOF vs DBVT Comparison

XPOF vs DBVT Comparison

Compare XPOF & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XPOF
  • DBVT
  • Stock Information
  • Founded
  • XPOF 2017
  • DBVT 2002
  • Country
  • XPOF United States
  • DBVT France
  • Employees
  • XPOF N/A
  • DBVT N/A
  • Industry
  • XPOF Services-Misc. Amusement & Recreation
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • XPOF Consumer Discretionary
  • DBVT Health Care
  • Exchange
  • XPOF Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • XPOF 295.1M
  • DBVT 250.5M
  • IPO Year
  • XPOF 2021
  • DBVT N/A
  • Fundamental
  • Price
  • XPOF $9.86
  • DBVT $11.06
  • Analyst Decision
  • XPOF Buy
  • DBVT Buy
  • Analyst Count
  • XPOF 9
  • DBVT 4
  • Target Price
  • XPOF $13.94
  • DBVT $14.81
  • AVG Volume (30 Days)
  • XPOF 724.9K
  • DBVT 29.5K
  • Earning Date
  • XPOF 07-31-2025
  • DBVT 07-29-2025
  • Dividend Yield
  • XPOF N/A
  • DBVT N/A
  • EPS Growth
  • XPOF N/A
  • DBVT N/A
  • EPS
  • XPOF N/A
  • DBVT N/A
  • Revenue
  • XPOF $317,536,000.00
  • DBVT $3,497,000.00
  • Revenue This Year
  • XPOF $1.62
  • DBVT $1,700.53
  • Revenue Next Year
  • XPOF $6.11
  • DBVT $535.67
  • P/E Ratio
  • XPOF N/A
  • DBVT N/A
  • Revenue Growth
  • XPOF N/A
  • DBVT N/A
  • 52 Week Low
  • XPOF $6.64
  • DBVT $2.21
  • 52 Week High
  • XPOF $18.95
  • DBVT $12.78
  • Technical
  • Relative Strength Index (RSI)
  • XPOF 62.03
  • DBVT 60.59
  • Support Level
  • XPOF $8.86
  • DBVT $10.52
  • Resistance Level
  • XPOF $10.14
  • DBVT $11.99
  • Average True Range (ATR)
  • XPOF 0.52
  • DBVT 0.70
  • MACD
  • XPOF 0.26
  • DBVT 0.21
  • Stochastic Oscillator
  • XPOF 87.25
  • DBVT 73.35

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: